Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, indicating a minor software update to the page's underlying framework. This change does not indicate any visible alterations to the study details or user-facing content based on the provided data.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page now indicates that enrollment has closed ('No longer looking for participants'). It also adds new sections and headings for user guidance and study details (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment), reflecting a reorganized information layout.SummaryDifference0.4%

- Check33 days agoChange DetectedNew revision entry v3.5.5 appears in the history and the old revision v3.5.4 is removed. This indicates an update to the site's underlying version rather than changes to trial content.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change is an internal version update and does not modify the visible content or user-facing features.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdated the page’s software/revision version indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check83 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.